SPI
18.465,76
PKT
-85,33
PKT
-0,46
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.04.12 | Nestlé halten | Independent Research GmbH | |
| 24.04.12 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 24.04.12 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 24.04.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 24.04.12 | Ypsomed hold | Vontobel Research | |
| 24.04.12 | Novartis underperform | Cheuvreux SA | |
| 24.04.12 | ams-OSRAM buy | Vontobel Research | |
| 24.04.12 | Swisscom equal-weight | Morgan Stanley | |
| 24.04.12 | Novartis hold | Vontobel Research | |
| 24.04.12 | Nestlé hold | ING | |
| 23.04.12 | Givaudan neutral | Sarasin Research | |
| 23.04.12 | Novartis buy | Nomura | |
| 23.04.12 | Novartis buy | Sarasin Research | |
| 23.04.12 | Nestlé outperform | Cheuvreux SA | |
| 23.04.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 23.04.12 | Mobimo buy | Sarasin Research | |
| 23.04.12 | Nestlé halten | Independent Research GmbH | |
| 20.04.12 | Nestlé buy | Sarasin Research | |
| 20.04.12 | Nestlé hold | ING | |
| 20.04.12 | ABB (Asea Brown Boveri) hold | ING | |
| 19.04.12 | BB Biotech kaufen | Independent Research GmbH | |
| 19.04.12 | Bucher Industries neutral | Sarasin Research | |
| 19.04.12 | Schindler buy | Sarasin Research | |
| 18.04.12 | Swiss Re underperform | RBC Capital Markets | |
| 18.04.12 | Swiss Re buy | Sarasin Research | |
| 18.04.12 | Allreal neutral | Sarasin Research | |
| 17.04.12 | Sulzer buy | Sarasin Research | |
| 17.04.12 | Sika neutral | Sarasin Research | |
| 17.04.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 16.04.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 16.04.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 13.04.12 | EMS-CHEMIE buy | Sarasin Research | |
| 13.04.12 | OC Oerlikon buy | Société Générale Group S.A. (SG) | |
| 13.04.12 | Roche outperform | Exane-BNP Paribas SA | |
| 12.04.12 | UBS underperform | Exane-BNP Paribas SA | |
| 12.04.12 | Orascom Development neutral | Sarasin Research | |
| 12.04.12 | Roche outperform | Cheuvreux SA | |
| 12.04.12 | Holcim outperform | Cheuvreux SA | |
| 12.04.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 12.04.12 | Holcim underperform | Cheuvreux SA |